Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response. (Q53845558)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

title

Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

author name string

Omdal R

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

Wildhagen K

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

Hansen T

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

Gunnarsson R

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

Kristoffersen G

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

publication date

1 May 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

published in

Scandinavian Journal of Rheumatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

volume

34

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

page(s)

229-232

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

cites work

Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

Pathogenesis of ANCA-associated systemic vasculitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

Antigen-specific interaction between T and B cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F02813430510015269

retrieved

21 January 2018

Identifiers

DOI

10.1080/02813430510015269

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

PubMed publication ID

16134730

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16134730

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/16134730

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53845558&oldid=870753099"